Fasciola hepatica: Histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks

Veterinary Parasitology

Volumn 191, Issue 3-4, 2013, Pages 240-251

  Hanna, R E B ^a   Forster, F I ^a   Brennan, G P ^b   Fairweather, I ^b  

^a AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Apoptosis; Fasciola hepatica; Histology; In situ hybridisation; Reproductive organs; Triclabendazole sensitive and resistant isolates

Indexed keywords

ENDONUCLEASE; TRICLABENDAZOLE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; EPIDEMIC; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; GENITAL SYSTEM; GERM CELL; HETEROPHAGY; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MEIOSIS; METACERCARIA; MICROTUBULE; MITOSIS; NICK END LABELING; NONHUMAN; OVARY; PARASITE ISOLATION; RAT; SPERMATOCYTE; SPERMATOGENESIS; SPERMATOGONIUM; TESTIS; TREMATODE; YOLK SAC;

ANIMALS; ANTHELMINTICS; APOPTOSIS; BENZIMIDAZOLES; DNA BREAKS; DRUG RESISTANCE; ENDONUCLEASES; FASCIOLA HEPATICA; FEMALE; GENITALIA; IN SITU NICK-END LABELING; MALE; SHEEP;

FASCIOLA HEPATICA;

EID: 84870884361     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.09.014     Document Type: Article

References (36)

1. Bjorkman N., Thorsell W. On the ultrastructure of the ovary of the liver fluke (Fasciola hepatica L.). Z. Zellforsch. Mikrosk. Anat. 1964, 63:538-549.
2. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Schellenbaum M., Von Orelli M., Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 1983, 113:315-317.
3. Cohen G.M., Sun X.M., Snowden R.T., Dinsdale D., Skilleter D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 1992, 286:331-334.
4. Compton M.M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 1992, 11:105-119.
5. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Enhancement of triclabendazole action against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole. Vet. Parasitol. 2011, 177:305-315.
6. Duvall E., Wyllie A.H. Death and the cell. Immunol. Today 1986, 7:115-119.
7. Fairweather I., Boray J.C. Mechanisms of fasciolicide action and drug resistance in Fasciola hepatica. Fasciolosis 1999, 225-276. CABI Publishing, Wallingford, Oxon, (Chapter 7). J.P. Dalton (Ed.).
8. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 2005, 79:227-234.
9. Fairweather I. Triclabendazole progress report, 2005-2009: an advancement of learning?. J. Helminthol. 2009, 83:139-150.
10. Fairweather I. Liver fluke isolates: a question of provenance. Vet. Parasitol. 2011, 176:1-8.
11. Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?. Vet. Parasitol. 2011, 180:133-143.
12. Fairweather I. Raising the bar on reporting 'triclabendazole resistance'. Vet. Rec. 2011, 168:514-515.
13. Fairweather I., McShane D.D., Shaw L., Ellison S.E., O'Hagan N.T., York E.A., Trudgett A., Brennan G.P. Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept. Vet. Parasitol. 2012, 183:249-259.
14. Flanagan A.M., Edgar H.W.J., Forster F., Gordon A., Hanna R.E.B., McCoy M., Brennan G.P., Fairweather I. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica. Vet. Parasitol. 2011, 176:34-42.
15. Flanagan A.M., Edgar H.W.J., Gordon A., Hanna R.E.B., Brennan G.P., Fairweather I. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep. Vet. Parasitol. 2011, 176:170-176.
16. Fletcher H.L., Hoey E.M., Orr N., Trudgett A., Fairweather I., Robinson M.W. The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica. Parasitology 2004, 128:69-72.
17. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992, 119:493-501.
18. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.-P., Toyka K.V., Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 1994, 71:219-225.
19. Gorczyca W., Bigman K., Mittelman A., Ahmed T., Gong J., Melamed M.R., Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemia. Leukemia 1993, 7:659-670.
20. Gresson R.A.R. Electron microscopy of the ovary of Fasciola hepatica. Q. J. Microsc. Sci. 1964, 105:213-218.
21. Hanna R.E.B., Edgar H., Moffett D., McConnell S., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M., Cromie C., Taylor S.M., Daniel R. Fasciola hepatica: histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts. Vet. Parasitol. 2008, 157:222-234.
22. Hanna R.E.B., Edgar H.W.J., McConnell S., Toner E., McConville M., Brennan G.P., Devine C., Flanagan A., Halferty L., Meaney M., Shaw L., Moffett D., McCoy M., Fairweather I. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, compound alpha. Vet. Parasitol. 2010, 168:240-254.
23. Hanna R.E.B., Scarcella S., Solana H., McConnell S., Fairweather I. Early onset of changes to the reproductive system of Fasciola hepatica following in vivo treatment with triclabendazole. Vet. Parasitol. 2012, 184:341-347.
24. Hanna R.E.B., Moffett D., Brennan G.P., Fairweather I. Fasciola hepatica: a light and electron microscope study of sustentacular tissue and heterophagy in the testis. Vet. Parasitol. 2012, 187:168-182.
25. Hennessy D.R., Lacey E., Steel J.W., Prichard R.K. The kinetics of triclabendazole disposition in sheep. J. Vet. Pharmacol. Ther. 1987, 10:64-72.
26. Irwin S.W.B., Threadgold L.T. Electron microscope studies on Fasciola hepatica. VIII. The development of the vitelline cells. Exp. Parasitol. 1970, 28:399-411.
27. Kumar V., Abbas A.K., Fausto N. Robbins and Cotran Pathologic Basis of Disease 2005, Elsevier Saunders, Philadelphia, PA, pp. 26-32. seventh ed.
28. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 1988, 8:399-404.
29. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., Hanna R.E.B., McCoy M., Gordon A.W., Castillo R., Hernández-Campos A., Fairweather I. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Vet. Parasitol. 2009, 162:75-88.
30. Olaechea F., Lovera V., Larroza M., Raffo F., Cabrera R. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). Vet. Parasitol. 2011, 178:364-366.
31. Overend D.J., Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 1995, 72:275-276.
32. Threadgold L.T. Stereological analysis of vitelline cell development. Exp. Parasitol. 1982, 54:352-365.
33. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 172:238-248.
34. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 174:218-227.
35. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W., Fairweather I. Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2011, 177:79-89.
36. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole. Parasitol. Res. 2011, 109:1035-1043.